3-cyclopentyl-3-(4-(2-(4-(diethylamino)phenylamino)-5-methylpyrimidin-4-yl)-1H-pyrazol-1-yl)propanenitrile | 1153937-51-9

• 分子结构分类: 有机化合物 - 有机氮化合物
• 英文名称: 3-cyclopentyl-3-(4-(2-(4-(diethylamino)phenylamino)-5-methylpyrimidin-4-yl)-1H-pyrazol-1-yl)propanenitrile
• 英文别名: 3-Cyclopentyl-3-[4-[2-[4-(diethylamino)anilino]-5-methylpyrimidin-4-yl]pyrazol-1-yl]propanenitrile
• CAS: 1153937-51-9
• 化学式: C₂₆H₃₃N₇
• 分子量: 443.595
• InChiKey: HEKGNXPGUKSZNJ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.8
• 重原子数：
  33
• 可旋转键数：
  9
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.46
• 拓扑面积：
  82.7
• 氢给体数：
  1
• 氢受体数：
  6

文献信息

• [EN] 4-PYRAZOLYL-N-ARYLPYRIMIDIN-2-AMINES AND 4-PYRAZOLYL-N-HETEROARYLPYRIMIDIN-2-AMINES AS JANUS KINASE INHIBITORS<br/>[FR] 4-PYRAZOLYL-N-ARYLPYRIMIDIN-2-AMINES ET 4-PYRAZOLYL-N-HÉTÉROARYLPYRIMIDIN-2-AMINES EN TANT QU'INHIBITEURS DE JANUS KINASE
  申请人：INCYTE CORP

  公开号：WO2009064835A1

  公开（公告）日：2009-05-22

  The present invention provides substituted bicyclic heteroaryl compounds, 5 including, for example, 4-pyrazoIyI-N-arylpyrirnidin-2-arnines and 4-pyrazolyl-N-heteroarylpyτimidin-2-amines that modulate the activity of kinases and are useful in the treatment of diseases related to activity of kinases including, for example, immune-related diseases, skin disorders, myeloid proliferative disorders, cancer, and other diseases.formule :(1)

  本发明提供了取代的双环杂环芳基化合物，包括例如4-吡唑基-N-芳基吡啶-2-胺和4-吡唑基-N-杂环芳基嘧啶-2-胺，这些化合物调节激酶的活性，在治疗与激酶活性相关的疾病方面具有用处，例如免疫相关疾病、皮肤疾病、髓细胞增生性疾病、癌症和其他疾病。公式：(1)
• [EN] JANUS KINASE INHIBITORS FOR TREATMENT OF DRY EYE AND OTHER EYE RELATED DISEASES<br/>[FR] INHIBITEURS DES JANUS KINASES POUR LE TRAITEMENT DU SYNDROME DE L'OEL SEC ET AUTRES MALADIES DE L'OEL
  申请人：INCYTE CORP

  公开号：WO2010039939A1

  公开（公告）日：2010-04-08

  Methods, kits, and compositions for treating dry eye disorders and other related eye diseases are provided, wherein the methods, kits, and compositions utilize a JAK inhibitor.

  本发明提供了用于治疗干眼症和其他相关眼部疾病的方法、试剂盒和组合物，其中所述方法、试剂盒和组合物利用JAK抑制剂。
• JANUS KINASE INHIBITORS FOR TREATMENT OF DRY EYE AND OTHER EYE RELATED DISEASES
  申请人：Incyte Holdings Corporation

  公开号：EP3042655A1

  公开（公告）日：2016-07-13

  Methods, kits, and compositions for treating dry eye disorders and other related eye diseases are provided, wherein the methods, kits, and compositions utilize a JAK inhibitor.

  提供了治疗干眼症和其他相关眼部疾病的方法、试剂盒和组合物，其中所述方法、试剂盒和组合物利用JAK抑制剂。
• 4-PYRAZOLYL-N-ARYLPYRIMIDIN-2-AMINES AND 4-PYRAZOLYL-N-HETEROARYLPYRIMIDIN-2-AMINES AS JANUS KINASE INHIBITORS
  申请人：Li Yun-Long

  公开号：US20090318405A1

  公开（公告）日：2009-12-24

  The present invention provides substituted bicyclic heteroaryl compounds, including, for example, 4-pyrazolyl-N-arylpyrimidin-2-amines and 4-pyrazolyl-N-heteroarylpyrimidin-2-amines that modulate the activity of kinases and are useful in the treatment of diseases related to activity of kinases including, for example, immune-related diseases, skin disorders, myeloid proliferative disorders, cancer, and other diseases.

  本发明提供了替代的双环杂环芳基化合物，包括例如4-吡唑基-N-芳基嘧啶-2-胺和4-吡唑基-N-杂环芳基嘧啶-2-胺，这些化合物可以调节激酶的活性，对于与激酶活性相关的疾病的治疗具有用处，包括例如免疫相关疾病、皮肤疾病、髓细胞增生性疾病、癌症和其他疾病。
• METHOD OF TREATING MUSCULAR DEGRADATION
  申请人：Rigel Pharmaceuticals, Inc.

  公开号：US20130310340A1

  公开（公告）日：2013-11-21

  A method for treating muscular deterioration is disclosed. Also disclosed are embodiments of a compound, and compositions comprising the compound, for inhibiting muscular deterioriation, including atrophy, dystrophy, and cachexia, such as may result from ventilation.